India vows action if cough syrup proved to be behind Gambia deaths | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Monday
June 16, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
MONDAY, JUNE 16, 2025
India vows action if cough syrup proved to be behind Gambia deaths

South Asia

Reuters
06 October, 2022, 08:05 pm
Last modified: 06 October, 2022, 08:04 pm

Related News

  • WHO warns of falsified cough syrup ingredients seized in Pakistan
  • India firm denies tampering with tests in probe of cough syrup deaths
  • Indonesian court papers reveal chain of events that led to cough syrup deaths
  • Indian firms linked to cough syrup deaths had received warnings
  • Uzbekistan starts trial over 65 child deaths linked to contaminated cough syrups

India vows action if cough syrup proved to be behind Gambia deaths

Reuters
06 October, 2022, 08:05 pm
Last modified: 06 October, 2022, 08:04 pm
The four medicines are cough and cold syrups produced in India, said the WHO statement.(Picture courtesy: Shutterstock)
The four medicines are cough and cold syrups produced in India, said the WHO statement.(Picture courtesy: Shutterstock)

Summary

  • Cough syrup made by India's Maiden Pharma linked to 66 deaths
  • Maiden says trying to find out from Gambia buyer what happened
  • Maiden says not selling any product in India currently
  • India health ministry seeks details from WHO
  • India health ministry vows to take "all required steps"

India is testing samples of cough syrups produced by Maiden Pharmaceuticals after the World Health Organization said its products were linked to the deaths of dozens of children in Gambia, a government official said on Thursday.

The deaths of 66 children in the West African country is a blow to India's image as a "pharmacy of the world" that supplies medicines to all continents, especially Africa. The cough syrup was made by New Delhi-based Maiden Pharmaceuticals, the WHO said.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Gambia urgently recalls India-made cough syrups blamed for 66 child deaths

"Samples have been sent to a central pharmaceutical laboratory for testing," Anil Vij, the health minister of Haryana state where Maiden has its factories, told reporters. "Strict action will be taken if anything is found wrong."

The federal health ministry would take all "required steps" in the matter, two officials said, adding that India was awaiting a report establishing "causal relation to death with the medical products in question" from the WHO.

Naresh Kumar Goyal, a Maiden director, told Reuters it heard about the deaths only on Thursday morning and were trying to find out details.

"We are trying to find out the situation because it cropped up only today," he said by phone. "We are trying to find out with the buyer and all that what has happened exactly. We are not selling anything in India."

He declined to speak further.

WHO Director-General Tedros Adhanom Ghebreyesus told reporters on Wednesday that the U.N. agency was investigating the deaths from acute kidney injuries with India's drug regulator and the drug maker.

The agency informed the Drugs Controller General of India of the deaths late last month after which the regulator launched an investigation with state authorities, in tandem with the WHO, the two India health ministry sources said.

The ministry has not issued a statement.

The WHO said laboratory analysis of Maiden cough syrup had confirmed "unacceptable" amounts of diethylene glycol and ethylene glycol, which can be toxic and lead to acute kidney injury.

Maiden, which launched its operations in November 1990, manufactured and exported the syrup only to Gambia, the Indian ministry sources said. Maiden says on its website it has two manufacturing plants, in Kundli and Panipat, both near New Delhi in Haryana, and has recently set up another one.

It has an annual production capacity of 2.2 million syrup bottles, 600 million capsules, 18 million injections, 300,000 ointment tubes and 1.2 billion tablets.

Maiden says on its website it sells its products at home and exports to countries in Asia, Africa and Latin America, though Goyal said they were not currently selling in India.

The two health ministry sources said that importing countries typically test such products before allowing their use.

The WHO said the Maiden products - Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup - may have been distributed elsewhere through informal markets but it had only been identified in Gambia.

World+Biz

India-made cough syrups / cough syrup

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Bangladesh High Commissioner to the United Kingdom Saida Muna Tasneem. Photo: Collected
    ACC launches inquiry against ex-UK envoy Saida Muna, husband over laundering Tk2,000cr
  • Shakib Al Hasan. File Photo: Collected
    Travel ban imposed on Shakib Al Hasan, 14 others over corruption allegations
  • BNP Standing Committee Member Salahuddin Ahmed. Photo: Collected
    BNP urges govt to inform EC of Yunus-Tarique's London meeting decision on election

MOST VIEWED

  • Bangladesh Bank Governor Ahsan H Mansur. TBS Sketch
    Merger of 5 Islamic banks at final stage: BB governor
  • UCB launches Bangladesh's first microservices-based open API banking platform
    UCB launches Bangladesh's first microservices-based open API banking platform
  • Photo: Collected
    Pakistan rejects reports of missile supply to Iran
  • Non-performing loans surge by Tk74,570cr in Q1 as hidden rot exposed
    Non-performing loans surge by Tk74,570cr in Q1 as hidden rot exposed
  • Crore-taka bank accounts edge down by 719 in March quarter
    Crore-taka bank accounts edge down by 719 in March quarter
  • Nepal begins 38MW hydropower export to Bangladesh
    Nepal begins 38MW hydropower export to Bangladesh

Related News

  • WHO warns of falsified cough syrup ingredients seized in Pakistan
  • India firm denies tampering with tests in probe of cough syrup deaths
  • Indonesian court papers reveal chain of events that led to cough syrup deaths
  • Indian firms linked to cough syrup deaths had received warnings
  • Uzbekistan starts trial over 65 child deaths linked to contaminated cough syrups

Features

The GLS600 overall has a curvaceous nature, with seamless blends across every panel. PHOTO: Arfin Kazi

Mercedes Maybach GLS600: Definitive Luxury

5h | Wheels
Renowned authors Imdadul Haque Milon, Mohit Kamal, and poet–children’s writer Rashed Rouf seen at Current Book Centre, alongside the store's proprietor, Shahin. Photo: Collected

From ‘Screen and Culture’ to ‘Current Book House’: Chattogram’s oldest surviving bookstore

22h | Panorama
Photos: Collected

Kurtis that make a great office wear

2d | Mode
Among pet birds in the country, lovebirds are the most common, and they are also the most numerous in the haat. Photo: Junayet Rashel

Where feathers meet fortune: How a small pigeon stall became Dhaka’s premiere bird market

4d | Panorama

More Videos from TBS

ICT orders newspapers ads summoning Hasina to appear before tribunal on 24 June

ICT orders newspapers ads summoning Hasina to appear before tribunal on 24 June

1h | TBS Today
Who was IRGC intelligence chief Kazemi killed in Israeli strike?

Who was IRGC intelligence chief Kazemi killed in Israeli strike?

2h | TBS World
Yunus-Tareq meeting; What Amir Khusru said after returning home after participating

Yunus-Tareq meeting; What Amir Khusru said after returning home after participating

3h | TBS Today
Iran launches missile attack on Israel again

Iran launches missile attack on Israel again

3h | TBS World
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net